The influence of beta-adrenergic blocking drugs on morbidity and mortality in heart failure.
Fowler
M B
MB
Division of Cardiovascular Medicine, Stanford University, California, USA.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D006801:Humans; D009017:Morbidity; D016019:Survival Analysis; D016277:Ventricular Function, Left
D000319:Adrenergic beta-Antagonists